Paper33101030
Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite.
Honrao C and 9 others. Front Pharmacol, 2020. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite. Papers, record 33101030. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33101030
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R21 DA032020 | NIDA NIH HHS | United States | R21DA032020 | PubMed and NIH | NIH RePORTER |
| R33 DA032020 | NIDA NIH HHS | United States | R21DA032020 | PubMed and NIH | NIH RePORTER |
| R37 DA003801 | NIDA NIH HHS | United States | R01DA003801 | PubMed and NIH | NIH RePORTER |
| P01 DA009158 | NIDA NIH HHS | United States | P01DA009158 | PubMed and NIH | NIH RePORTER |
| R01 DA003801 | NIDA NIH HHS | United States | R01DA003801 | PubMed and NIH | NIH RePORTER |
| R33DA032020 | NIH | NIH RePORTER | |||
| R37DA003801 | NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 33,967,764 | Corrigendum: Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite. | https://conductscience.org/library/papers/33967764 |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15,999,995 | Adamantyl cannabinoids: a novel class of cannabinergic ligands. | J Med Chem | 2005 | https://conductscience.org/library/papers/15999995 | PubMed |
| 2 | 15,638,474 | High-throughput microcoil NMR of compound libraries using zero-dispersion segmented flow analysis. | J Comb Chem | 2005 | https://conductscience.org/library/papers/15638474 | PubMed |
| 3 | 25,957,385 | Identification of AKB-48 and 5F-AKB-48 Metabolites in Authentic Human Urine Samples Using Human Liver Microsomes and Time of Flight Mass Spectrometry. | J Anal Toxicol | 2015 | https://conductscience.org/library/papers/25957385 | PubMed |
| 4 | 15,698,792 | Synthesis, structure-activity relationship, and p210(bcr-abl) protein tyrosine kinase activity of novel AG 957 analogs. | Bioorg Med Chem | 2005 | https://conductscience.org/library/papers/15698792 | PubMed |
| 5 | 18,235,504 | Structural basis for the function and inhibition of an influenza virus proton channel. | Nature | 2008 | https://conductscience.org/library/papers/18235504 | PubMed |
| 6 | 30,639,103 | Crystal Structure of the Human Cannabinoid Receptor CB2. | Cell | 2019 | https://conductscience.org/library/papers/30639103 | PubMed |
| 7 | 25,849,525 | Activation of cannabinoid CB2 receptors reduces hyperalgesia in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis. | Neurosci Lett | 2015 | https://conductscience.org/library/papers/25849525 | PubMed |
| 8 | 19,748,066 | Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin--diabetes control and potential adverse events. | Best Pract Res Clin Endocrinol Metab | 2009 | https://conductscience.org/library/papers/19748066 | PubMed |
| 9 | 26,002,511 | CYP3A4 Mediates Oxidative Metabolism of the Synthetic Cannabinoid AKB-48. | AAPS J | 2015 | https://conductscience.org/library/papers/26002511 | PubMed |
| 10 | 23,913,126 | First characterization of AKB-48 metabolism, a novel synthetic cannabinoid, using human hepatocytes and high-resolution mass spectrometry. | AAPS J | 2013 | https://conductscience.org/library/papers/23913126 | PubMed |
| 11 | 18,834,150 | Microscale LC-MS-NMR platform applied to the identification of active cyanobacterial metabolites. | Anal Chem | 2008 | https://conductscience.org/library/papers/18834150 | PubMed |
| 12 | 26,792,810 | Analysis of Parent Synthetic Cannabinoids in Blood and Urinary Metabolites by Liquid Chromatography Tandem Mass Spectrometry. | J Anal Toxicol | 2016 | https://conductscience.org/library/papers/26792810 | PubMed |
| 13 | 15,144,211 | Microflow NMR: concepts and capabilities. | Anal Chem | 2004 | https://conductscience.org/library/papers/15144211 | PubMed |
| 14 | 15,891,249 | Combination therapy with adapalene gel 0.1% and doxycycline for severe acne vulgaris: a multicenter, investigator-blind, randomized, controlled study. | Skinmed | 2005 | https://conductscience.org/library/papers/15891249 | PubMed |
| 15 | 12,672,860 | Memantine in moderate-to-severe Alzheimer's disease. | N Engl J Med | 2003 | https://conductscience.org/library/papers/12672860 | PubMed |
| 16 | 29,790,809 | Characterization of in vitro and in vivo metabolism of leelamine using liquid chromatography-tandem mass spectrometry. | Xenobiotica | 2019 | https://conductscience.org/library/papers/29790809 | PubMed |
| 17 | 18,542,883 | Microcoil NMR spectroscopy: a novel tool for biological high throughput NMR spectroscopy. | Methods Mol Biol | 2008 | https://conductscience.org/library/papers/18542883 | PubMed |
| 18 | 24,028,148 | Nuclear magnetic resonance at the picomole level of a DNA adduct. | Chem Res Toxicol | 2013 | https://conductscience.org/library/papers/24028148 | PubMed |
| 19 | 26,584,231 | OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins. | J Chem Theory Comput | 2016 | https://conductscience.org/library/papers/26584231 | PubMed |
| 20 | 28,537,398 | Discovery of Clinical Candidate 2-((2S,6S)-2-Phenyl-6-hydroxyadamantan-2-yl)-1-(3'-hydroxyazetidin-1-yl)ethanone [BMS-816336], an Orally Active Novel Selective 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor. | J Med Chem | 2017 | https://conductscience.org/library/papers/28537398 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CLINT1 | 9,685 | PubTator's text mining | https://conductscience.org/library/genes/9685 | NCBI Gene |
| CNR2 | 1,269 | PubTator's text mining | https://conductscience.org/library/genes/1269 | NCBI Gene |
| CYP3A4 | 1,576 | PubTator's text mining | https://conductscience.org/library/genes/1576 | NCBI Gene |
| PPIG | 9,360 | PubTator's text mining | https://conductscience.org/library/genes/9360 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33101030
GET https://conductscience.org/api/papers/v1/33101030/references?page=2